LS presents with a highly heterogeneous phenotype, as shown by substantial differences in cancer penetrance (lifetime cancer risk) and expressivity (malignancies in specific organs) among individuals harboring genetic variants in a specific altered MMR gene [3]. This evidence concerns the gene MRC1 and Leigh syndrome.